We are presenting the Korean Life Science Market Trend Analysis 2021 prepared in cooperation with our partner Seoul BioHub operated by KHIDI (Korea Health Industry Development Institute). South Korea is one of the definite leaders in the Asian life science market, with nearly 1,300 medtech and biotech assets in development and over 1,100 clinical trials registered within the last decade.
Would you like to be notified about new reports and other valuable content published by Biotechgate?